Advanced Search
Disease Phase
Title Drug
Clinical Trials Listing
  • < Previous
  • 1
  • Next >
  • Penn Treatment Trials (4)
  • Penn Non-Treatment Trials (7)
  • Phase 1: Solid Tumor Trials (0)
  • Proton Therapy Trials (0)
Active treatment trials at Penn's Abramson Cancer Center
Protocol ID Title Phase Modality Drug
04-21 Phase III MultiCenter Randomized Controlled Study to Assess Efficacy and Safety of ON 01910.Na 72-Hr Continuous IV Infusion in MDS Patients With Excess Blasts Relapsing After or Refractory to or Intolerant to Azacitidine or Decitabine III Signal Transduction Inhibitor rigosertib
709 A Randomized, Multi-Center, Phase III Study of Allogeneic Stem Cell Transplantation Comparing Regimen Intensity in Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia III Bone Marrow Transplant / Stem Cell Transplant, Chemotherapy fludarabine; busulfan; melphalan; cyclophosphamide
UPCC 15411 A Phase I-II Open Label Non-Randomized Study Using TL32711 for Patients With Acute Myelogenous Leukemia, Myelodysplastic Syndrome and Acute Lymphoblastic Leukemia I / II Biological Therapy birinapant
UPCC 24412 A Phase I Dose Escalation Study to Investigate the Safety, Pharmacokinetics, Immunoregulatory Activity, and Preliminary Antitumor Activity of Anti-Programmed-Death 1 (PD-1) Antibody (BMS-936558) in Subjects With Relapsed or Refractory Hematologic Malignancy I Immunotherapy BMS-936558
Displaying: 1 - 4 of 4 Results
  • < Previous
  • 1
  • Next >